Unity Biotechnology, Inc. (UNBX)
OTCMKTS · Delayed Price · Currency is USD
0.0699
-0.0002 (-0.29%)
At close: Sep 15, 2025
Unity Biotechnology Market Cap
Unity Biotechnology has a market cap or net worth of $1.20 million as of September 16, 2025. Its market cap has decreased by -95.72% in one year.
Market Cap
1.20M
Enterprise Value
6.88M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.07
Market Cap Chart
Since May 3, 2018, Unity Biotechnology's market cap has decreased from 697.69M to 1.20M, a decrease of -99.83%. That is a compound annual growth rate of -57.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 1.20M | -92.69% |
| Dec 31, 2024 | 16.45M | -49.21% |
| Dec 29, 2023 | 32.39M | -16.69% |
| Dec 30, 2022 | 38.89M | -53.86% |
| Dec 31, 2021 | 84.28M | -69.60% |
| Dec 31, 2020 | 277.27M | -16.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 3, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 782.91M |
| Elite Pharmaceuticals | 735.19M |
| Glass House Brands | 548.40M |
| Northwest Biotherapeutics | 379.14M |
| American Oncology Network | 353.52M |
| CytoDyn | 351.92M |